ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994

ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief.

January 18, 2002

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Sharp Increase In Cancer Mortality Could Bring Drastic Program Changes; All 1975 Data Needed

December 12, 1975

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993